Target intelligence / Profile preview

Parasitic glucose transporter (PfHT, LmGT1–3, CsGLUT)

Target
PfHT, LmGT1–3, CsGLUT
Molecular classification
Transporter, Major Facilitator Superfamily (MFS), Uniporter
01

Overview

Glucose transporter proteins in parasitic protozoa and some helminths are integral membrane proteins belonging to the major facilitator superfamily (MFS), facilitating the import of glucose (and often other hexoses) across the parasite plasma membrane. Parasites such as Plasmodium, Leishmania, and Trypanosoma rely heavily on glucose for energy due to limited metabolic pathways, making these transporters essential for growth, replication, and virulence. Multiple transporter isoforms may be present, each with distinct expression patterns and subcellular localizations; for example, Leishmania mexicana expresses LmGT1 in flagella, and LmGT2/3 in the cell body. Inhibition of these transporters using small molecules can effectively starve parasites of glucose, offering a promising strategy for novel antiparasitic drugs, but selectivity and safety remain key challenges due to the similarity to human transporters.

Other names
Parasitic glucose transporterHexose transporterPfHT (Plasmodium)LmGT1LmGT2LmGT3 (Leishmania)GLUT (generalized)GTP (Clonorchis)Sugar transporter
02

Mechanism of action

Inhibition of glucose uptake—drugs block glucose binding or transport, starving the parasite of energy and leading to growth inhibition or death

03

Biological functions

Nutrient uptake (glucose absorption)Energy metabolism (glycolysis)Parasite survival and proliferation inside host cells
04

Disease associations

Infection (malaria, leishmaniasis, sleeping sickness, cryptosporidiosis, schistosomiasis)Other parasitic diseases
05

Safety considerations

Potential toxicity due to cross-reactivity with human glucose transporters, especially GLUT1Need for selectivity to avoid hypoglycemia in patientsOverlap in substrate specificity and structure between parasite and host transporters
06

Interacting drugs

Compound 3361 (selective PfHT inhibitor)

2 more in the full profile.

07

Biomarkers

Expression levels of parasite glucose transporters (e.g. PfHT mRNA/protein)Reduction of glucose uptake in parasite cultures

Beyond the preview

Go deeper on Parasitic glucose transporter (PfHT, LmGT1–3, CsGLUT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasitic glucose transporter (PfHT, LmGT1–3, CsGLUT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call